logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12201642 B1

PDFFull Text
Date of Patent:
Jan. 21, 2025

Filed:

Jan. 25, 2021

Composition for the treatment of covid-19

Applicants:

Kartar Singh Lalvani, London, GB;

Robert Taylor, London, GB;

Rohit Shelatkar, London, GB;

Inventors:

Kartar Singh Lalvani, London, GB;

Robert Taylor, London, GB;

Rohit Shelatkar, London, GB;

Assignee:
Attorney:

Laubscher & Fretwell, P.C.

Primary Examiner:

Bethany P Barham

Assistant Examiner:

Peter Anthopolos

Int. Cl.
CPC ...
A61K 31/616 (2006.01); A61K 31/137 (2006.01); A61K 31/375 (2006.01); A61K 31/455 (2006.01); A61K 31/5415 (2006.01); A61K 31/593 (2006.01); A61K 31/7034 (2006.01); A61K 33/04 (2006.01); A61K 33/18 (2006.01); A61K 33/30 (2006.01); A61K 36/76 (2006.01); A61P 31/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/616 (2013.01); A61K 31/137 (2013.01); A61K 31/375 (2013.01); A61K 31/455 (2013.01); A61K 31/5415 (2013.01); A61K 31/593 (2013.01); A61K 31/7034 (2013.01); A61K 33/04 (2013.01); A61K 33/18 (2013.01); A61K 33/30 (2013.01); A61K 36/76 (2013.01);
Abstract

A formulation provides a unique synergistic composition for the treatment of the novel Coronavirus (COVID-19). Due to multiple mechanisms and synergy of action of the ingredients involved, using drug and nutrient therapy to support the body's natural immune response, it can provide a significant advantage to currently used therapies and may also be administered prophylactically. In its optimal embodiment the composition can be prepared in solid (tablet or capsule) or liquid form, containing Aspirin or any natural salicinoid, Phenylephrine, Promethazine, Vitamin D, Vitamin C, Niacinamide, Iodine Zinc and Selenium.

Find Patent Forward Citations

Lalvani, Kartar. (2025). Composition for the treatment of covid-19 (U.S. Patent No. 12201642). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12201642

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…